medline.ch Onkologie Urologische Tumoren

	Tissue Memory Score captures proximal tubular identity loss and independently stratifies survival in clear cell renal cell carcinoma. Urol Oncol Khalil S, Hamdan M. PMID: 42542400 [PubMed - as supplied by publisher]
	Comment on "Olaparib combined with abiraterone in HRR-mutated metastatic hormone-sensitive prostate cancer: a single-arm phase II trial". World J Urol Yusuf SM, Sattar A, Sharabu R. PMID: 42541579 [PubMed - in process]
	Reirradiation of locally recurrent prostate Cancer: a review of prospective evidence and delineation and planning strategies from the reirradiation Collaborative group (ReCOG). Clin Transl Radiat Oncol Slevin F, Warkentin B, Hansen J, Henry AM, Murray LJ, Murrell DH, Ong WL, Pasquier D. PMID: 42540621 [PubMed]
	Diagnosis of metastatic prostate cancer by supraclavicular lymph node excision in a patient with persistent macroscopic hematuria: A case report. Urol Case Rep Drozda V, Cierna Z, Harmanos M, Cvik M. PMID: 42540607 [PubMed]
	Predicting Poor Efficacy of Cabozantinib in Advanced Renal Cell Carcinoma by Exploratory Metabolic Pathway Analysis and InÂ Vitro Verification. Cancer Med Sakai T, Kawasaki Y, Sakamoto I, Hishinuma E, Matsukawa N, Chiba D, Sato T, Morozumi K, Maekawa M, Mano N, Ito A. PMID: 42538613 [PubMed - indexed for MEDLINE]
	Performance of Urine Tumor DNA Detection in Patients with High-grade Non-muscle-invasive Bladder Cancer Undergoing Repeat Transurethral Resection. Eur Urol Focus Ogunkeye J, Shkolyar E, Mach KE, Prendiville S, Prado K, Shah JB, Skinner EC, Fischer DS, Phillips KG, Bicocca VT, Levin TG, Liao JC. PMID: 42538173 [PubMed - as supplied by publisher]
	Activation of the PI3K/AKT/mTOR signaling pathway in bladder cancer pathogenesis and its therapeutic significance. Cancer Treat Res Commun Bogale DE. PMID: 42537446 [PubMed - as supplied by publisher]
	Venous thromboembolism in urothelial bladder cancer - scope of the problem and patients' perspectives: VTE-UBC. Wiad Lek Abdullah OR, Short K, Alomari LHF, Ignatowicz A, Young A. PMID: 42536929 [PubMed - indexed for MEDLINE]
	Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City. Oncology (Williston Park) Rodríguez-Olivares JL, Mauricio Mora Pineda Md, Beas-Lozano E, Alec Seidman-Sorsby Md, Remolina-Bonilla YA, Armando Gamboa-Domínguez Md, Jeffrey Weitzel Md Facmg, Pedro Barata Md MSc, Yanin Chavarri-Guerra Md MSc Fasco, Bourlon MT. PMID: 42536596 [PubMed - indexed for MEDLINE]
	An immunohistochemical diagnostic panel for Xp11.2 translocation renal cell carcinoma: A diagnostic accuracy study. Medicine (Baltimore) Wei M, Pan B, Yang W, Xu W, Dong J. PMID: 42536557 [PubMed - indexed for MEDLINE]
	Risk of bladder cancer among male participants reporting nocturia in the Cancer Prevention Study-II. Cancer Epidemiol Biomarkers Prev Zhong C, Masters M, Donzella SM, Bliwise DL, Parsons H, Rees-Punia E. PMID: 42536351 [PubMed - as supplied by publisher]
	Circadian Gene Networks and Transcriptome Oscillations in Prostate Cancer: Insights From RNA Sequencing and Implications for Chronotherapy. Cureus Bivolarski I, Dimitrov M, Dechev H. PMID: 42535191 [PubMed]
	Indian Delphi consensus on cardiovascular risk mitigation in prostate cancer management. Front Oncol Bakshi G, Lyon A, Joshi A, Agarwala V, Raghunath SK, Addla SK, Taneja R, Mandani A, Kashyapi B, Bhargava S, Sharma R, Agrawal V, Nagar R, Srivathsan R, Patel K, Patel R, Shah H, Lai A, Mukherjee A, Pandey S, Rajput A. PMID: 42534891 [PubMed]
	AI-driven precision diagnosis and treatment of prostate cancer: a narrative review. Front Oncol Chu T, Zhang Y, Du J, Mierxiati A. PMID: 42534734 [PubMed]
	Apalutamide-induced prostate-specific antigen response and its association with clinical outcomes in metastatic castration sensitive prostate cancer (Review). Mol Clin Oncol N S, Mv C, Upadhyay A, Sonone P, Dharmadhikari S, Puppalwar G, Khandhedia C, Mane A, Mehta S. PMID: 42534213 [PubMed]
	[(18)F]PSMA-1007 PET-Based Recurrence Site Distribution and Predictors of Metastatic Disease in Patients With Biochemical Recurrence of Prostate Cancer. Int J Urol Hatano K, Watabe T, Hirata T, Konishi M, Kanaki T, Tani M, Oka T, Ishizuya Y, Hayashi T, Yamamoto Y, Kato T, Kawashima A, Fujita K, Uemura M, Giesel FL, Nonomura N. PMID: 42533777 [PubMed - indexed for MEDLINE]
	Oncological Outcomes and Prognostic Factors of Platinum-Based Chemotherapy Followed by Avelumab Maintenance Therapy Compared With Platinum-Based Chemotherapy Alone: A Propensity Score-Matched Analysis in a Real-World Population. Int J Urol Matsushita Y, Kita Y, Mukai S, Joraku A, Kobayashi I, Daizumoto K, Sano T, Nakanishi S, Watanabe J, Hatakeyama S, Goriki A, Hazama T, Nishiyama N, Mori K, Kitamura H, Kimura T, Matsui Y, Miyake M, Kobayashi T, Inamoto T, Japanese Urological Oncology Group. PMID: 42533764 [PubMed - indexed for MEDLINE]
	Full-Component Chart-Derived Lee Score, Upfront Androgen Receptor Signaling Inhibitor Selection, and Competing Mortality in Metastatic Hormone-Sensitive Prostate Cancer. Geriatr Gerontol Int Kurokawa K, Yamamoto S, Higa K, Bamba H, Kanaoka S, Nakamura K. PMID: 42533722 [PubMed - indexed for MEDLINE]
	Challenges of Bone Scintigraphy in Assessment of Osseous Metastases in Prostate Cancer: Why it is Time to Reconsider Role of (1)â¸F-NaF PET/CT. Mol Imaging Biol Zirakchian Zadeh M. PMID: 42533239 [PubMed - as supplied by publisher]
	Tumor and Organ Dose Estimates from (177)Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial. J Nucl Med Ells Z, Meyer C, Masri K, Ryhiner M, Sennung D, Kimura K, Mirando D, Tworowska I, Esfandiari R, Allen-Auerbach MS, Lassmann M, Herrmann K, Eiber M, Fendler WP, Delpassand E, Czernin J, Dahlbom M, Calais J. PMID: 42532646 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 180443

Seite 1 von 9023

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung